Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Trial of Ciclesonide in Adults with Mild COVID-19
KCT0005105Phase 2Completed
- Sponsor
- Ministry of Science and ICT
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ciclesonide in coronavirus disease 2019 (COVID-19), sponsored by Ministry of Science and ICT. Started Apr 2020; status: completed.
02
Drugs
ciclesonide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on KCT0005105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005105.